Veru’s enobosarm showed significant body composition benefits in Phase 2b trials with semaglutide. Extension study results are due in April 2025.
Veru Shares Tumble Despite Enobosarm’s Lean Muscle Preservation Breakthrough
Where Today's News Shapes Tomorrow
